Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor.

de Groot M, Teunissen MB, Ortonne JP, Lambert JR, Naeyaert JM, Picavet DI, Arreaza MG, Simon JS, Kraan M, Bos JD, de Rie MA.

Arch Dermatol Res. 2007 Sep;299(7):305-13. Epub 2007 Jul 24.

2.

CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial.

van Kuijk AW, Vergunst CE, Gerlag DM, Bresnihan B, Gomez-Reino JJ, Rouzier R, Verschueren PC, van der Leij C, Maas M, Kraan MC, Tak PP.

Ann Rheum Dis. 2010 Nov;69(11):2013-6. doi: 10.1136/ard.2010.131235. Epub 2010 Aug 6. Erratum in: Ann Rheum Dis. 2013 Apr;72(4):630. van de Leij, Christiaan [corrected to van der Leij, Christiaan].

PMID:
20693270
3.

Increased expression of RANTES, CCR3 and CCR5 in the lesional skin of patients with atopic eczema.

Kato Y, Pawankar R, Kimura Y, Kawana S.

Int Arch Allergy Immunol. 2006;139(3):245-57. Epub 2006 Jan 30.

PMID:
16449815
4.

The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis.

Otkjaer K, Kragballe K, Funding AT, Clausen JT, Noerby PL, Steiniche T, Iversen L.

Br J Dermatol. 2005 Nov;153(5):911-8.

PMID:
16225599
5.

Expression of chemokine receptor CXCR3 by lymphocytes and plasmacytoid dendritic cells in human psoriatic lesions.

Chen SC, de Groot M, Kinsley D, Laverty M, McClanahan T, Arreaza M, Gustafson EL, Teunissen MB, de Rie MA, Fine JS, Kraan M.

Arch Dermatol Res. 2010 Mar;302(2):113-23. doi: 10.1007/s00403-009-0966-2. Epub 2009 Jun 11.

PMID:
19517126
6.

Expression of CCL5 (RANTES) and CCR5 in prostate cancer.

Vaday GG, Peehl DM, Kadam PA, Lawrence DM.

Prostate. 2006 Feb 1;66(2):124-34.

PMID:
16161154
7.

Preferential expression of T(h)2-type chemokine and its receptor in atopic dermatitis.

Uchida T, Suto H, Ra C, Ogawa H, Kobata T, Okumura K.

Int Immunol. 2002 Dec;14(12):1431-8.

PMID:
12456591
8.

Anti-E-selectin is ineffective in the treatment of psoriasis: a randomized trial.

Bhushan M, Bleiker TO, Ballsdon AE, Allen MH, Sopwith M, Robinson MK, Clarke C, Weller RP, Graham-Brown RA, Keefe M, Barker JN, Griffiths CE.

Br J Dermatol. 2002 May;146(5):824-31.

PMID:
12000379
9.

Increased expression of TRAIL and its death receptors DR4 and DR5 in plaque psoriasis.

Peternel S, Prpić-Massari L, Manestar-Blažić T, Brajac I, Kaštelan M.

Arch Dermatol Res. 2011 Aug;303(6):389-97. doi: 10.1007/s00403-011-1125-0. Epub 2011 Jan 29.

PMID:
21279373
10.

Macrophages infiltrating the tissue in chronic pancreatitis express the chemokine receptor CCR5.

Goecke H, Forssmann U, Uguccioni M, Friess H, Conejo-Garcia JR, Zimmermann A, Baggiolini M, Büchler MW.

Surgery. 2000 Nov;128(5):806-14.

PMID:
11056444
11.

Th1- and Th2-related chemokine and chemokine receptor expression on the ocular surface in endotoxin-induced uveitis.

Trinh L, Brignole-Baudouin F, Pauly A, Liang H, Houssier M, Baudouin C.

Mol Vis. 2008;14:2428-34. Epub 2008 Dec 19.

12.

CC chemokine receptor 5 (CCR5) mRNA expression in pulmonary sarcoidosis.

Petrek M, Gibejova A, Drabek J, Mrazek F, Kolek V, Weigl E, du Bois RM.

Immunol Lett. 2002 Mar 1;80(3):189-93.

PMID:
11803051
13.

Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis.

Raychaudhuri SP, Jiang WY, Farber EM, Schall TJ, Ruff MR, Pert CB.

Acta Derm Venereol. 1999 Jan;79(1):9-11.

PMID:
10086850
14.
15.
16.

The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor.

Watson C, Jenkinson S, Kazmierski W, Kenakin T.

Mol Pharmacol. 2005 Apr;67(4):1268-82. Epub 2005 Jan 11.

17.

Downregulation of SMAD2, 4 and 6 mRNA and TGFbeta receptor I mRNA in lesional and non-lesional psoriatic skin.

Yu H, Mrowietz U, Seifert O.

Acta Derm Venereol. 2009;89(4):351-6. doi: 10.2340/00015555-0634.

18.

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo.

Strizki JM, Xu S, Wagner NE, Wojcik L, Liu J, Hou Y, Endres M, Palani A, Shapiro S, Clader JW, Greenlee WJ, Tagat JR, McCombie S, Cox K, Fawzi AB, Chou CC, Pugliese-Sivo C, Davies L, Moreno ME, Ho DD, Trkola A, Stoddart CA, Moore JP, Reyes GR, Baroudy BM.

Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12718-23. Epub 2001 Oct 16.

19.

The effects of oral liarozole on epidermal proliferation and differentiation in severe plaque psoriasis are comparable with those of acitretin.

Kuijpers AL, Van Pelt JP, Bergers M, Boegheim PJ, Den Bakker JE, Siegenthaler G, Van de Kerkhof PC, Schalkwijk J.

Br J Dermatol. 1998 Sep;139(3):380-9.

PMID:
9988537
20.

Supplemental Content

Support Center